Literature DB >> 33520796

Gene set enrichment analysis of α-amylase and α-glucosidase inhibitors of Cassia glauca.

Shama G Ternikar1, M B Patil2, Ismail Pasha3, Pukar Khanal4.   

Abstract

BACKGROUND: The present study aimed to evaluate in vitro α-amylase and α-glucosidase inhibitory activity of various extracts of Cassia glauca, predict the binding affinity of multiple phytoconstituents with both enzymes via in silico molecular docking and identify the probably modulated pathways by the lead hit.
METHODS: Different extracts of Cassia glauca i.e. acetone, ethanol, and aqueous extracts were evaluated for α-amylase and α-glucosidase inhibitory activity using in vitro method in which starch and 4-Nitrophenyl β-D-glucopyranoside were used as substrate respectively. Similarly, the docking study was performed using autodock4 to predict the binding affinity of phytoconstituents with α-amylase and α-glucosidase. After docking, ten different poses were obtained for the ligand molecule. Among them, the pose of ligand molecule with the lowest binding energy was visualized in Discovery Studio 2019. RESULTS AND
CONCLUSION: Among the multiple extracts, the aqueous extract showed the highest α-amylase (IC50:652.10 ± 20.09) and α-glucosidase (IC50:482.46 ± 8.70) inhibitory activity. Similarly, cassiaoccidentalin B was predicted to have the highest binding affinity with both enzymes. The potency of aqueous extract to inhibit α-amylase and α-glucosidase could be due to multiple water-soluble compounds like saponins, flavonoids, and glycosides. © Springer Nature Switzerland AG 2020.

Entities:  

Keywords:  Cassia glauca; Cassiaoccidentalin B; Docking; In vitro anti-diabetic activity

Year:  2020        PMID: 33520796      PMCID: PMC7843725          DOI: 10.1007/s40200-020-00538-9

Source DB:  PubMed          Journal:  J Diabetes Metab Disord        ISSN: 2251-6581


  13 in total

1.  Pharmacotherapy of Diabetes: Past, Present, and Future: Preface.

Authors:  R Keith Campbell
Journal:  Diabetes Spectr       Date:  2014-05

Review 2.  alpha-Glucosidase inhibitors.

Authors:  H E Lebovitz
Journal:  Endocrinol Metab Clin North Am       Date:  1997-09       Impact factor: 4.741

3.  alpha-Glucosidase inhibitory profile of catechins and theaflavins.

Authors:  Toshiro Matsui; Takashi Tanaka; Satomi Tamura; Asami Toshima; Kei Tamaya; Yuji Miyata; Kazunari Tanaka; Kiyoshi Matsumoto
Journal:  J Agric Food Chem       Date:  2007-01-10       Impact factor: 5.279

4.  Antidiabetic activity of aqueous bark extract of Cassia glauca in streptozotocin-induced diabetic rats.

Authors:  Md Salahuddin; Sunil S Jalalpure; Navneet B Gadge
Journal:  Can J Physiol Pharmacol       Date:  2010-02       Impact factor: 2.273

5.  Protective effect of Cassia glauca Linn. on the serum glucose and hepatic enzymes level in streptozotocin induced NIDDM in rats.

Authors:  Mamta Farswan; Papiya Mitra Mazumder; V Percha
Journal:  Indian J Pharmacol       Date:  2009-02       Impact factor: 1.200

Review 6.  Molecular docking as a popular tool in drug design, an in silico travel.

Authors:  Jerome de Ruyck; Guillaume Brysbaert; Ralf Blossey; Marc F Lensink
Journal:  Adv Appl Bioinform Chem       Date:  2016-06-28

Review 7.  Emerging Roles of p53 Family Members in Glucose Metabolism.

Authors:  Yoko Itahana; Koji Itahana
Journal:  Int J Mol Sci       Date:  2018-03-08       Impact factor: 5.923

8.  In silico Prediction, Characterization, Molecular Docking, and Dynamic Studies on Fungal SDRs as Novel Targets for Searching Potential Fungicides Against Fusarium Wilt in Tomato.

Authors:  Mohd Aamir; Vinay Kumar Singh; Manish Kumar Dubey; Mukesh Meena; Sarvesh Pratap Kashyap; Sudheer Kumar Katari; Ram Sanmukh Upadhyay; Amineni Umamaheswari; Surendra Singh
Journal:  Front Pharmacol       Date:  2018-10-22       Impact factor: 5.810

9.  In-vitro α-amylase and α-glucosidase inhibitory activity of Adiantum caudatum Linn. and Celosia argentea Linn. extracts and fractions.

Authors:  Madhusudhan Telagari; Kirankumar Hullatti
Journal:  Indian J Pharmacol       Date:  2015 Jul-Aug       Impact factor: 1.200

10.  Antidiabetic activity of Chandraprabha vati - A classical Ayurvedic formulation.

Authors:  Manish M Wanjari; Sujata Mishra; Yadu Nandan Dey; Deepti Sharma; Sudesh N Gaidhani; Ankush D Jadhav
Journal:  J Ayurveda Integr Med       Date:  2016-09-22
View more
  3 in total

1.  Identification of α-amylase inhibitors from flavonoid fraction of Feronia elephantum and its integration with in-silico studies.

Authors:  Saikiran Kulkarni; Prarambh Dwivedi; Aravinda Nagaraj Danappanvar; Belgaonkar Ashwini Subhash; B M Patil
Journal:  In Silico Pharmacol       Date:  2021-08-10

2.  Gene ontology enrichment analysis of PPAR-γ modulators from Cassia glauca in diabetes mellitus.

Authors:  Shama G Ternikar; M B Patil; Ismail Pasha; Prarambh S R Dwivedi
Journal:  J Diabetes Metab Disord       Date:  2021-09-02

3.  Exploring the therapeutic mechanisms of Cassia glauca in diabetes mellitus through network pharmacology, molecular docking and molecular dynamics.

Authors:  Prarambh S R Dwivedi; Rajesh Patil; Pukar Khanal; Nilambari S Gurav; Vaishali D Murade; Dinesh P Hase; Mohan G Kalaskar; Muniappan Ayyanar; Rupesh V Chikhale; Shailendra S Gurav
Journal:  RSC Adv       Date:  2021-12-09       Impact factor: 4.036

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.